Company

Altevax Biotech

Pharmaceutical Manufacturing Paris, Fr 6 employees

Employees: 6
Contacts: 2
Emails: 2

altevax.com LinkedIn Crunchbase

Altevax Biotech Overview

Headquarters: Paris, Fr
Phone Number: Available in AeroLeads
Website: altevax.com
Industry: Pharmaceutical Manufacturing
Employees: 6
Founded: 2016
Company Email: Available in AeroLeads
NAICS: Pharmaceutical and Medicine Manufacturing

Medicinal and Botanical Manufacturing

Pharmaceutical Preparation Manufacturing

Keywords

Cancer vaccines immunotherapy melanin therapeutic vaccines Peptidic vaccines infectious diseases CD8 Killer T cells Immuno-oncology

About Altevax Biotech

Altevax is developing a powerful pioneering immunotherapy technology against cancer. Its patented melanin-based technology has been proven in pre-clinical trials to boost an antigen-specific immune response with Cytotoxic T-lymphocytes (CD8+ Killer T cells), the body’s most powerful defenders. The Altevax immunotherapy technology works with a wide range of peptides. The Altevax technology is complementary to other anti-cancer immune technologies, such as anti PD1s. Altevax is developing an immunotherapy against glioblastoma, currently in advanced pre-clinical development, with Phase 1/2a expected in early 2024. Altevax's partnership with Assistance Publique Hôpitaux de Paris and other research institutions enables it to leverage their resources and accelerate clinical trials.

Altevax Biotech Contact Details

People in AeroLeads: 4
With contact data: 2
Email contacts: 2; 50.0% coverage

Altevax Biotech Org Chart

Sample employees and titles

Name	Title	Location	Contact
Endi Musarais	Business Development Director	Greater Paris Metropolitan Region, France	Email
Paul Van Der Schueren	President at Ogloba	Brussels, Brussels Region, Belgium	Email
Benoit Roch	Pharmd, Phd - R&D - Pre-clinical		View
Catherine Martre	CEO Meletios Therapeutics		View